[F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland

被引:27
|
作者
Jadvar, Hossein [1 ]
Ye, Wei [1 ]
Groshen, Susan [1 ]
Conti, Peter S. [1 ]
机构
[1] Univ So Calif, Dept Radiol & Biomed Engn, PET Imaging Sci Ctr, Los Angeles, CA 90033 USA
关键词
Prostate; FDG; PET-CT;
D O I
10.1007/s12149-008-0177-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective We determined the glucose metabolism and computed tomographic (CT) density of the normal prostate gland in relation to age and prostate size on [ F-18]fluorodeoxyglucose positron emission tomography (PET)-CT. Methods We determined the CT density (Hounsfield Units, HU) and glucose metabolism (standardized uptake value, SUV) of the normal prostate in 145 men (age range 22-97 years) on PET-CT scans which were performed for indications unrelated to prostate pathology. Correlations among SUV, HU, prostate size, and age were calculated using Pearson's correlation coefficients, scatter plots, and linear regression trend lines. The SUV and HU values were also compared among different primary cancer types using the Kruskal-Wallis test. Results The population average and range of the normal prostate size were 4.3 +/- 0.5 cm (mean +/- SD) and 2.9-5.5 cm, respectively. The population average of mean and maximum CT densities was 36.0 +/- 5.1 HU (range 23-57) and 91.7 +/- 20.1 HU (range 62-211), respectively. The population average of mean and maximum SUV was 1.3 +/- 0.4 (range 0.1-2.7) and 1.6 +/- 0.4 (range 1.1-3.7), respectively. Mean SUV tended to decrease as the prostate size increased (r = -0.16, P = 0.058). Higher mean HU was correlated with higher mean SUV (r = 0.18, P = 0.033). The strongest association was observed between age and prostate size. The prostate gets larger as age increases (r = 0.32, P < 0.001). Prostate mean SUV, max SUV, mean HU, and max HU were not significantly different among different types of primary cancers. Conclusions Although the normal prostate size increases with age, it does not significantly affect the gland's metabolism and CT density, and therefore age correction of these parameters may be unnecessary.
引用
收藏
页码:787 / 793
页数:7
相关论文
共 50 条
  • [31] F-18 FDG PET/CT imaging of submandibular gland oncocytoma
    Subramaniam, Rathan M.
    Durnick, David K.
    Peller, Patrick J.
    CLINICAL NUCLEAR MEDICINE, 2008, 33 (07) : 472 - 474
  • [32] F-18 Fluor Choline PET/CT vs F-18 Fluoride PET/CT in the detection of bone metastases in patients with prostate cancer
    Beheshti, M.
    Fitz, F.
    Haim, S.
    Nader, M.
    Poecher, S.
    Jordanova, N.
    Stoiber, F.
    Loidl, W.
    Langsteger, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S208 - S209
  • [33] NEUROIMAGING .1. PET WITH [F-18]FLUORODEOXYGLUCOSE
    TAMMINGA, CA
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (10): : 1415 - 1415
  • [34] Differential diagnosis of parkinsonism with [F-18]fluorodeoxyglucose and PET
    Kazumata, K
    Ishikawa, T
    Dhawan, V
    Feigin, A
    Mandel, F
    Margouleff, C
    Eidelberg, D
    NEUROLOGY, 1996, 46 (02) : 6087 - 6087
  • [35] [F-18]Fluorodeoxyglucose PET in Large Vessel Vasculitis
    Walter, Martin A.
    PET CLINICS, 2006, 1 (02) : 179 - +
  • [36] F-18 FDG PET-CT in Fitz-Hugh-Curtis Syndrome
    Tan, Teik Hin
    Rajasuriar, Jay Suriar
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2022, 21 (02) : 166 - 168
  • [37] The Role of F-18 FDG PET-CT for Detecting Second Primary Neoplasms
    Abdulrezzak, U.
    Orhan, E.
    Tutus, A.
    Kula, M.
    Berk, V.
    Karaca, H.
    Gundog, M.
    Eroglu, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S592 - S592
  • [38] F-18 Choline PET-CT is valuable in the assessment of normocalcemic primary hyperparathyroidism
    Pirich, C.
    Schaffler-Schaden, D.
    Schweighofer-Zwink, G.
    Rendl, G.
    Hehenwarter, L.
    Beheshti, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S133 - S133
  • [39] Maffucci Syndrome With Extraosseous Chondrosarcoma Imaged With F-18 FDG PET-CT
    Makis, William
    Hickeson, Marc
    Lisbona, Robert
    CLINICAL NUCLEAR MEDICINE, 2010, 35 (01) : 29 - 31
  • [40] To assess the role of F-18 FDG PET-CT in management of adrenocortical carcinoma
    Mohan, N.
    Shamim, S.
    Arora, S.
    Passah, A.
    Baghel, V.
    Roma, R.
    Gupta, S. Datta
    Rastogi, S.
    Bal, C. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S548 - S548